Studies of the cross-reactivity of antibodies to core glycolipid with assorted isolated, heterologous lipopolysaccharides (LPSs) confirm the conservation of core glycolipid epitopes among gram-negative bacterial species. However, the accessibility of core glycolipid epitopes to antibody in the intact bacterial cell may be affected by the cell surface structure. In studies with 125I-labeled monoclonal antibodies to core glycolipid that cross-react with isolated LPS, the degree to which antibodies can bind to LPS in the outer membrane of intact, viable, gram-negative bacterial cells was found to vary with the strain of bacteria tested. Sequestration of bacterial cell-bound LPS from antibody was confirmed in a smooth strain of Escherichia coli by means of immunoelectron microscopy. The inability of antibody to bind to membrane-bound LPS suggests that such sequestered LPS may also be unable to effect toxicity in the infected host until liberated by bacterial cell breakdown.
No takes yet. Share an insight, caveat, or question.
Shenep et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: